Literature DB >> 8484689

Prevalence of rheumatoid arthritis and rheumatoid factor in women: evidence for a secular decline.

T D Spector1, D J Hart, R J Powell.   

Abstract

OBJECTIVE: To determine the current prevalence of rheumatoid arthritis (RA) and rheumatoid factor positivity in the United Kingdom middle aged female population and to compare this with previous estimates to assess whether the disease is becoming less prevalent.
METHODS: A cross sectional prevalence study was undertaken. All women aged 45-64 from the age and sex register of a large 11,000 general practitioner group practice in Chingford, East London were contacted and responders examined clinically and radiographically for the presence of RA by a single observer. Blood was also taken for rheumatoid factor testing (sheep cell agglutination test (SCAT), latex, and IgG). The prevalence in non-attenders was assessed from general practitioner and local hospital records. A diagnosis of definite or classical RA according to 1958 American Rheumatism Association criteria was used, and seropositivity was defined by a SCAT rheumatoid factor of 1/32 or more.
RESULTS: From the 1003 women examined (response rate of 78.8%), 12 women had definite RA (1.2%, 95% confidence interval 0.6 to 1.8). Of these, 7/12 had definite erosive changes on radiography and 3/12 had a positive SCAT (> 1/32). Three cases of RA were also found in the 284 non-responders (prevalence 1.1%) by case-finding techniques. The rate of SCAT positivity in the whole study group was 0.5%. The rates of RA and SCAT positivity currently found in this group were less than those obtained in previous surveys. In the only previous large scale United Kingdom survey, performed in the north of England between 1958 and 1960, 406 women aged 45-64 were examined and 10 cases of definite RA were found, a prevalence of 2.5%. In the patients with RA 68% had erosions and 63% positive SCAT. The population SCAT positive rate in this and other surveys sampled between 1954 and 1961 was in the range of 4-5%, since when there has been a progressive decline according to a number of other studies.
CONCLUSIONS: The prevalence of RA and rheumatoid factor in middle aged women is lower than previously believed and supports a variety of other data which indicate that RA is declining in incidence and severity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8484689      PMCID: PMC1005621          DOI: 10.1136/ard.52.4.254

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  20 in total

1.  Epidemiology of the sheep cell agglutination test.

Authors:  J BALL; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1961-09       Impact factor: 19.103

2.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

3.  Oral contraceptives and rheumatoid arthritis: new data from the Royal College of General Practitioners' oral contraception study.

Authors:  P C Hannaford; C R Kay; S Hirsch
Journal:  Ann Rheum Dis       Date:  1990-10       Impact factor: 19.103

4.  Has the incidence of rheumatoid arthritis declined in the United Kingdom?

Authors:  A J Silman
Journal:  Br J Rheumatol       Date:  1988-02

5.  Rheumatoid factor in Iceland: a population study.

Authors:  E Allander; O J Björnsson; A Kolbeinsson; O Olafsson; N Sigfússon; J Thorsteinsson
Journal:  Int J Epidemiol       Date:  1972       Impact factor: 7.196

6.  The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality.

Authors:  A Linos; J W Worthington; W M O'Fallon; L T Kurland
Journal:  Am J Epidemiol       Date:  1980-01       Impact factor: 4.897

Review 7.  Rheumatoid arthritis.

Authors:  T D Spector
Journal:  Rheum Dis Clin North Am       Date:  1990-08       Impact factor: 2.670

8.  The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytic epidemiological studies using meta-analysis.

Authors:  T D Spector; M C Hochberg
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

9.  Autoantibodies, immunoglobulins and Gm allotypes in nodal generalized osteoarthritis.

Authors:  N D Hopkinson; R J Powell; M Doherty
Journal:  Br J Rheumatol       Date:  1992-09

10.  Rheumatoid arthritis in women. Incidence rates in group health cooperative, Seattle, Washington, 1987-1989.

Authors:  C E Dugowson; T D Koepsell; L F Voigt; L Bley; J L Nelson; J R Daling
Journal:  Arthritis Rheum       Date:  1991-12
View more
  9 in total

Review 1.  Type 1 and type 2 immune responses in children: their relevance in juvenile arthritis.

Authors:  L R Wedderburn; P Woo
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Will the increasing prevalence of atopy have a favourable impact on rheumatoid arthritis?

Authors:  J S Gaston
Journal:  Ann Rheum Dis       Date:  1998-05       Impact factor: 19.103

3.  Prevalence of rheumatoid arthritis in Dublin, Ireland: a population based survey.

Authors:  D Power; M Codd; L Ivers; S Sant; M Barry
Journal:  Ir J Med Sci       Date:  1999 Jul-Sep       Impact factor: 1.568

4.  Orthopaedic surgery of the lower limbs in 49,802 rheumatoid arthritis patients: results from the Swedish National Inpatient Registry during 1987 to 2001.

Authors:  R J Weiss; A Stark; M C Wick; A Ehlin; K Palmblad; P Wretenberg
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

5.  Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis.

Authors:  D S Majka; K D Deane; L A Parrish; A A Lazar; A E Barón; C W Walker; M V Rubertone; W R Gilliland; J M Norris; V M Holers
Journal:  Ann Rheum Dis       Date:  2007-11-01       Impact factor: 19.103

6.  Is rheumatoid factor useful in primary care? A retrospective cross-sectional study.

Authors:  Anne Miller; Kamal R Mahtani; Margaret A Waterfield; Anthony Timms; Siraj A Misbah; Raashid A Luqmani
Journal:  Clin Rheumatol       Date:  2013-03-21       Impact factor: 2.980

7.  Prevalence of rheumatoid arthritis in the southern part of denmark.

Authors:  Jens K Pedersen; Anders J Svendsen; Kim Hørslev-Petersen
Journal:  Open Rheumatol J       Date:  2011-12-02

8.  Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study.

Authors:  Bogdan Batko; Marcin Stajszczyk; Jerzy Świerkot; Karol Urbański; Filip Raciborski; Mariusz Jędrzejewski; Piotr Wiland
Journal:  Arch Med Sci       Date:  2017-12-13       Impact factor: 3.318

9.  Ascendancy of weekly low-dose methotrexate in usual care of rheumatoid arthritis from 1980 to 2004 at two sites in Finland and the United States.

Authors:  T Sokka; T Pincus
Journal:  Rheumatology (Oxford)       Date:  2008-08-07       Impact factor: 7.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.